Final answer:
The nurse should provide information about RhoGam, including its administration to Rh mothers, its ability to prevent Rh antibodies, and its effectiveness in reducing the incidence of HDN.
Step-by-step explanation:
The nurse should provide the following information about the RhoGam injection:
- RhoGam, also known as Rh immune globulin, is a drug given to Rh mothers during weeks 26-28 of pregnancy and within 72 hours following birth.
- It can prevent the development of Rh antibodies in the mother's body, which helps to protect the fetus from a potentially serious disease called hemolytic disease of the newborn (HDN).
- RhoGam works by destroying any fetal Rh erythrocytes that may cross the placental barrier, decreasing the incidence of HDN from 13-14% to about 0.1% since its introduction in 1968.